The development of assays specific for dimeric inhibin A and inhibin B defined the distinct physiology of these two hormones in the normal menstrual cycle. Inhibin A and inhibin B expression and secretion along with their differential regulation by gonadotropins explain their unique serum patterns and their potential endocrine and ovarian autocrine-paracrine functions. There is evidence that inhibin A and inhibin B play an endocrine role in the negative regulation of follicle-stimulating hormone (FSH) in nonhuman primates and humans. However, some studies suggest that estradiol is a more important, if not the only, negative feedback regulator of FSH in women. There is also evidence from animal models that inhibins and activins play a critical role in follicle development. Future work will be necessary to define further the relative role of the inhibins, estradiol, and other autocrine-paracrine factors in these important reproductive functions.
KEYWORDS
Menstrual cycle - follicle-stimulating hormone - feedback - activin - follicle - inhibin
REFERENCES
-
1
McLachlan R I, Robertson D M, Healy D L, Burger H G, DeKretser D M.
Circulating immunoreactive inhibin levels during the normal menstrual cycle.
J Clin Endocrinol Metab.
1987;
65
954-961
-
2
Welt C K, Martin K A, Taylor A E et al..
Frequency modulation of FSH during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
J Clin Endocrinol Metab.
1997;
82
2645-2652
-
3
Lambert-Messerlian G M, Hall J E, Sluss P M et al..
Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay.
J Clin Endocrinol Metab.
1994;
79
45-50
-
4
Groome N P, Illingworth P J, O'Brien M et al..
Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay.
Clin Endocrinol (Oxf).
1994;
40
717-723
-
5
Groome N P, Illingworth P J, O'Brien M et al..
Measurement of dimeric inhibin B throughout the human menstrual cycle.
J Clin Endocrinol Metab.
1996;
81
1401-1405
-
6
Knight P G, Muttukrishna S, Groome N P.
Development and application of a two-site enzyme immunoassay for the determination of “total” activin-A concentrations in serum and follicular fluid.
J Endocrinol.
1996;
148
267-279
-
7
Schneyer A L, Rzucidlo D O, Sluss P M, Crowley Jr W F.
Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.
Endocrinology.
1994;
135
667-674
-
8
Demura R, Suzuki T, Tajima S et al..
Human plasma free activin and inhibin levels during the menstrual cycle.
J Clin Endocrinol Metab.
1993;
76
1080-1082
-
9
Muttukrishna S, Fowler P A, George L, Groome N P, Knight P G.
Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.
J Clin Endocrinol Metab.
1996;
81
3328-3334
-
10
McConnell D, Wang Q F, Sluss P M et al..
A two site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state.
J Clin Endocrinol Metab.
1998;
83
851-858
-
11
Khoury R H, Wang Q F, Crowley Jr W F et al..
Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin.
J Clin Endocrinol Metab.
1995;
80
1361-1368
-
12
Roberts V J, Barth S, El-Roeiy A, Yen S SC.
Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle.
J Clin Endocrinol Metab.
1993;
77
1402-1410
-
13
Welt C K, Schneyer A L.
Differential regulation of inhibin B and inhibin A by FSH and local growth factors in human granulosa cells from small antral follicles.
J Clin Endocrinol Metab.
2001;
86
330-336
-
14
Schneyer A L, Fujiwara T, Fox J et al..
Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.
J Clin Endocrinol Metab.
2000;
85
3319-3330
-
15
Magoffin D A, Jakimiuk A J.
Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women.
Hum Reprod.
1997;
12
1714-1719
-
16
Welt C K, Smith Z A, Pauler D K, Hall J E.
Differential regulation of inhibin A and inhibin B by LH, FSH and stage of follicle development.
J Clin Endocrinol Metab.
2001;
86
2531-2537
-
17
Welt C K, Adams J M, Sluss P M, Hall J E.
Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development.
J Clin Endocrinol Metab.
1999;
84
2163-2169
-
18
Hall J E, Welt C K, Cramer D W.
Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome.
Hum Reprod.
1999;
14
409-415
-
19
Dykema J C, Mayo K E.
Two messenger ribonucleic acids encoding the common βB-chain of inhibin and activin have distinct 5′-initiation sites and are differentially regulated in rat granulosa cells.
Endocrinology.
1994;
135
702-711
-
20
Feng Z M, Li Y P, Chen C -LC.
Analysis of the 5′-flanking regions of rat inhibin α- and β-B-subunit genes suggests two different regulatory mechanisms.
Mol Endocrinol.
1989;
3
1914-1925
-
21
Ardekani A M, Romanelli J CD, Mayo K E.
Structure of the rat inhibin and activin βA-subunit gene and regulation in an ovarian granulosa cell line.
Endocrinology.
1998;
139
3271-3279
-
22
Pei L, Dodson R, Schoderbek W E, Maurer R A, Mayo K E.
Regulation of the α inhibin gene by cyclic adenosine 3′,5′-monophosphate after transfection into rat granulosa cells.
Mol Endocrinol.
1991;
5
521-534
-
23
Eramaa M, Ritvos O.
Transforming growth factor-β1 and -β2 induce inhibin and activin βB-subunit messenger ribonucleic acid levels in cultured human granulosa-luteal cells.
Fertil Steril.
1996;
65
954-960
-
24
Eramaa M, Hilden K, Tuuri T, Ritvos O.
Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
Endocrinology.
1995;
136
4382-4389
-
25
Vanttinen T, Liu J, Liu J et al..
Regulation of immunoreactive inhibin A and B secretion in cultured human granulosa-luteal cells by gonadotropins, activin A and insulin-like growth factor type-1 receptor.
J Endocrinol.
2000;
167
289-294
-
26
Kaivo-Oja N, Bondestam J, Kamarainen M et al..
Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells.
J Clin Endocrinol Metab.
2003;
88
755-762
-
27
Jaatinen R, Bondestam J, Raivio T et al..
Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
J Clin Endocrinol Metab.
2002;
87
1254-1261
-
28
Buckler H M, McLachlan R I, MacLachlan V B, Healy D L, Burger H G.
Serum inhibin levels in polycystic ovary syndrome: basal levels and response to luteinizing hormone releasing hormone agonist and exogenous gonadotropin administration.
J Clin Endocrinol Metab.
1988;
66
798-803
-
29
Falcone T, Billiar R, Morris D.
Serum inhibin levels in PCOS: effect of insulin resistance and insulin secretion.
Obstet Gynecol.
1991;
78
171-176
-
30
Welt C K, Taylor A E, Martin K A, Hall J E.
Serum inhibin B in polycystic ovary syndrome: regulation by insulin and luteinizing hormone.
J Clin Endocrinol Metab.
2002;
87
5559-5565
-
31
Pigny P, Cortet-Rudelli C, Decanter C et al..
Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
Fertil Steril.
2000;
73
972-977
-
32
Cortet-Rudelli C, Pigny P, Decanter C et al..
Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.
Fertil Steril.
2002;
77
281-287
-
33
Norman R J, Milner C R, Groome N P, Robertson D M.
Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome.
Hum Reprod.
2001;
16
668-672
-
34
Laven J SE, Imani B, Eijkemans M JC, de Jong F H, Fauser B CJM.
Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility.
Hum Reprod.
2001;
16
1359-1364
-
35
Elting M W, Kwee J, Schats R, Rekers-Mombarg L TM, Shoemaker J.
The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
J Clin Endocrinol Metab.
2001;
86
1589-1595
-
36
Vale W, Rivier C, Hsueh A et al..
Chemical and biological characterization of the inhibin family of protein hormones.
Recent Prog Horm Res.
1988;
44
1-34
-
37
Stouffer R L, Dahl K D, Hess K L, Woodruff T K, Mather J P, Molskness T A.
Systemic and intraluteal infusion of inhibin A and activin A in rhesus monkeys during the luteal phase of the menstrual cycle.
Biol Reprod.
1994;
50
888-895
-
38
Fraser H M, Tsonis C G.
Manipulation of inhibin during the luteal-follicular phase transition of the primate menstrual cycle fails to affect FSH secretion.
J Endocrinol.
1994;
142
181-186
-
39
Fraser H M, Smith K B, Lunn S F, Cowen G M, Morris K, McNeilly A S.
Immunoneutralization and immunocytochemial localization of inhibin α subunit during the mid-luteal phase in the stump-tailed macaque.
J Endocrinol.
1992;
133
341-347
-
40
Le Nestour E, Marraoui J, Lahlou N, Roger M, De Ziegler D, Bouchard Ph.
Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.
J Clin Endocrinol Metab.
1993;
77
439-442
-
41
Lahlou N, Chabbert-Buffet N, Christin-Maitre S, Le Nestour E, Bouchard P.
Main inhibitor of follicle stimulating hormone in the luteal-follicular transition: inhibin A, oestradiol, or inhibin B?.
Hum Reprod.
1999;
14
1190-1193
-
42
Welt C K, McNicholl D, Taylor A E, Hall J E.
Female reproductive aging is marked by decreased secretion of dimeric inhibin.
J Clin Endocrinol Metab.
1999;
84
105-111
-
43
Reame N E, Wyman T L, Phillips D J, DeKretser D M, Padmanabhan V.
Net increase in stimulatory tone resulting from a decrease in inhibin-B and an increase in activin-A may contribute, in part, to the rise in follicular phase FSH of aging in cycling women.
J Clin Endocrinol Metab.
1998;
83
3302-3307
-
44
Klein N A, Illingworth P J, Groome N P, McNeilly A S, Battaglia D E, Soules M R.
Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles.
J Clin Endocrinol Metab.
1996;
81
2742-2745
-
45
Santoro N, Adel T, Skurnick J H.
Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women.
Fertil Steril.
1999;
71
658-662
-
46
Burger H G, Cahir N, Robertson D M et al..
Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.
Clin Endocrinol (Oxf).
1998;
48
809-813
-
47
Welt C K, Pagan Y L, Smith P C, Rado K B, Hall J E.
Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition.
J Clin Endocrinol Metab.
2003;
88
1766-1771
-
48
Molskness T A, Woodruff T K, Hess D L, Dahl K D, Stouffer R L.
Recombinant human inhibin A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
J Clin Endocrinol Metab.
1996;
81
4002-4006
-
49
Loria P, Petraglia F, Concari M et al..
Influence of age and sex on serum concentrations of total dimeric activin A.
Eur J Endocrinol.
1998;
139
487-492
-
50
Welt C K, Lambert-Messerlian G M, Zheng W, Crowley Jr W F, Schneyer A L.
The presence of activin, inhibin and follistatin in epithelial ovarian carcinoma.
J Clin Endocrinol Metab.
1997;
82
3720-3727
-
51
Woodruff T K, Lyon R, Hansen S, Rice G, Mather J.
Inhibin and activin locally regulate rat ovarian folliculogenesis.
Endocrinology.
1990;
127
3196-3205
-
52
El Hefnawy T, Zeleznik A J.
Synergism between FSH and activin in the regulation of proliferating cell nuclear antigen (PCNA) and cyclin D2 expression in rat granulosa cells.
Endocrinology.
2001;
142
4357-4362
-
53
Duleba A J, Pehlivan T, Carbone R, Spaczynski R Z.
Activin stimulates proliferation of rat ovarian thecal-interstitial cells.
Biol Reprod.
2001;
65
704-709
-
54
McMullen M L, Cho B N, Yates C J, Mayo K E.
Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit.
Endocrinology.
2001;
142
5005-5014
-
55
Brown C W, Houston-Hawkins D E, Woodruff T K, Matzuk M M.
Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions.
Nat Genet.
2000;
25
453-457
Corrine K WeltM.D.
Assistant Professor of Medicine, Reproductive Endocrine, Massachusetts General Hospital
BHX 511, 55 Fruit Street
Boston, MA 02114
